The CDCC is pleased to solicit applications for its Rapid Research Pilot Program. This RFA describes the first solicitation of the CDCC Rapid Research Pilot Program. This pilot program provides an expedited funding mechanism (CDCC subawards) to evaluate the feasibility of implementing emerging COVID-19 testing technologies in underserved communities.
The goal of the program is to improve access to and uptake of diagnostic COVID-19 testing in communities of underserved and vulnerable populations. The purpose of the overall program is to better understand factors that have led to the disproportionate impact of COVID-19 on these groups, and develop interventions to reduce those disparities. The RADx-UP program has multiple components, which are summarized at https://www.nih.gov/research-training/medical-research-initiatives/radx.
For the purpose of this RFA, populations that are underserved as well as populations that are COVID-19 vulnerable due to medical, geographic, and social factors, are defined below:
This Rapid Research Pilot Program is intended to provide an expedited mechanism to assess the feasibility of integrating novel or emerging technologies into RADx-UP in coordination with the NIH-supported RADx initiatives. Applicants should address a number of potential challenges including the following three (3) key areas: